Table 7.
Incremental cost-effectiveness ratio for scenario B.
| Strategy | Infection averted | Cost | IAR | ACER | ICER |
|---|---|---|---|---|---|
| Strategy 8: | 1.4524 | 0.0015 | 0.0015 | ||
| Strategy 6: | 1.5239 | −0.0078 | |||
| Strategy 7: | 1.4506 | 0.0068 | |||
| Strategy 5: | 1.5759 | −0.0016 |
Incremental cost-effectiveness ratio for scenario B.
| Strategy | Infection averted | Cost | IAR | ACER | ICER |
|---|---|---|---|---|---|
| Strategy 8: | 1.4524 | 0.0015 | 0.0015 | ||
| Strategy 6: | 1.5239 | −0.0078 | |||
| Strategy 7: | 1.4506 | 0.0068 | |||
| Strategy 5: | 1.5759 | −0.0016 |